Treatment

SS levels

Cv. Giza 843

Cv. Sakha 1

Cv. 716

F. m.

%

D. M.

%

F. M.

%

D. m.

%

F. m.

%

D. m.

%

C

4.9

100

0.856

100

4.49

100

1.56

100

15.1

100

2.9

100

20%

6.0

147.6

1.20

140.2

6.51

144.9

2.03

130.1

11.6

76.8

2.0

68.9

50%

8.7

177.8

1.98

231.3

6.59

146.8

2.51

160.9

5.9

39.1

1.1

37.9

70%

10.4

211.2

2.6

3.1.4

8.08

179.9

3.11

199.3

4.7

31.1

1.5

51.7

100%

9.92

202

2.2

252.3

2.27

50.7

0.33

21.1

4.5

29.8

0.95

32.7

C + IAA

7.54

153.6

1.5

171.7

13.7

305.1

2.78

187.9

6.9

45.7

1.3

44.8

20% + IAA

9.08

148.9

2.1

248.8

10.3

229.4

3.21

115.4

6.7

44.4

1.7

58.6

50% + IAA

11.8

241.9

2.7

320

12.7

282.8

4.82

308.9

8.6

56.9

1.5

51.2

70% + IAA

10.7

2 18.4

2.8

327.1

11.5

256.1

3.11

199.3

9.8

64.9

1.8

62.1

100% + IAA

10.4

211.8

2.2

257.0

10.4

231.6

1.40

89.7

9.77

64.7

1.9

65.5

C + SA

13.8

281

2.98

348.1

6.5

144.8

1.52

97.4

11.3

74.8

1.9

65.5

20% + SA

10.5

213.8

2.9

334.1

10.5

233.8

2.86

183.3

11.6

76.8

1.9

65.5

50% + SA

9.1

84.5

2.1

247.6

9.0

200.4

3.42

219.2

11.4

75.5

2.6

89.7

70% + SA

11.1

225.9

2.9

335.3

9.9

220.5

3.79

242.9

11.9

79.1

2.6

89.7

100% + SA

4.9

100

0.856

100

8.4

187.1

1.83

117.3

12.5

82.8

2.7

93.1

L. S. D. 0.05%

0.95

1.20

0.95

0.87

0.65

0.88